Literature DB >> 7416910

Premature deaths in schizophrenia and affective disorders. An analysis of survival curves and variables affecting the shortened survival.

M T Tsuang, R F Woolson, J A Fleming.   

Abstract

We have found shortened survival in 200 schizophrenics, 100 manics, and 225 depressives by comparing them with the Iowa general population. The numbers of years of shortened survival were estimated from the survival curves of each diagnostic group by sex. Variables affecting shortened survival were diagnostic group, sex, age at admission, and pay status at admission. Excess causes of death were suicides, accidents, and infective and circulatory system diseases. The absolute mortality for deaths due to neoplasm in our sample was not significantly different than that in the Iowa general population. However, the proportional mortality from the same data showed a deficiency in deaths due to neoplasm in schizophrenia and affective disorders. Well-designed epidemiologic studies are needed to see if there is a real deficiency in deaths due to cancer in the major psychoses.

Entities:  

Mesh:

Year:  1980        PMID: 7416910     DOI: 10.1001/archpsyc.1980.01780220017001

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  28 in total

Review 1.  Drug treatments for schizophrenia.

Authors:  C Adams; P Wilson; S Gilbody; A M Bagnall; R Lewis
Journal:  Qual Health Care       Date:  2000-03

2.  Suicidal behavior in adolescents with first-episode psychosis.

Authors:  Tatiana Falcone; Leenu Mishra; Erin Carlton; Catherine Lee; Robert S Butler; Damir Janigro; Barry Simon; Kathleen Franco
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-04

Review 3.  A tail with a thorn in it: second-generation antipsychotics hand in hand with statins.

Authors:  Ronen Durst; Eran Leitersdorf
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

Review 4.  Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 1: Depression and its treatment.

Authors:  J A Henry; C A Rivas
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

Review 5.  Co-morbidity of smoking in patients with psychiatric and substance use disorders.

Authors:  David Kalman; Sandra Baker Morissette; Tony P George
Journal:  Am J Addict       Date:  2005 Mar-Apr

6.  Greater body mass index is associated with reduced frontal cortical volumes among adolescents with bipolar disorder.

Authors:  Alvi H Islam; Arron W S Metcalfe; Bradley J MacIntosh; Daphne J Korczak; Benjamin I Goldstein
Journal:  J Psychiatry Neurosci       Date:  2018-03       Impact factor: 6.186

Review 7.  Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications.

Authors:  Nora Hamdani; Raphael Doukhan; Ozlem Kurtlucan; Ryad Tamouza; Marion Leboyer
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

8.  Prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder.

Authors:  Martha Sajatovic; Jennifer Levin; Luis F Ramirez; David Y Hahn; Curtis Tatsuoka; Christopher S Bialko; Kristin A Cassidy; Edna Fuentes-Casiano; Tiffany D Williams
Journal:  J Clin Psychiatry       Date:  2013-12       Impact factor: 4.384

9.  The health of the chronically mentally ill: a review of the literature.

Authors:  A A Lieberman; A F Coburn
Journal:  Community Ment Health J       Date:  1986

10.  Health care of the chronically mentally ill: the culture broker model.

Authors:  B Schwab; R E Drake; E M Burghardt
Journal:  Community Ment Health J       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.